{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:57:48Z","timestamp":1779116268361,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,11]]},"DOI":"10.7759\/cureus.83903","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T16:32:21Z","timestamp":1746981141000},"source":"Crossref","is-referenced-by-count":3,"title":["The Impact of New Weight-Loss Medications on Bariatric Surgery and Surgeon Employment"],"prefix":"10.7759","author":[{"given":"Mena","family":"Louis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2022_581","article-title":"Epidemiology of obesity","volume":"274","author":"S\u00f8rensen TI","year":"2022","unstructured":"S\u00f8rensen TI, Martinez AR, J\u00f8rgensen TS. Epidemiology of obesity. Handb Exp Pharmacol. 2022, 274:3-27. 10.1007\/164_2022_581","journal-title":"Handb Exp Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01548-4","article-title":"National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050","volume":"404","author":"GBD 2021 US Obesity Forecasting Collaborators","year":"2024","unstructured":"GBD 2021 US Obesity Forecasting Collaborators. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050. Lancet. 2024, 404:2278-98. 10.1016\/S0140-6736(24)01548-4","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz273","article-title":"Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic","volume":"49","author":"Wang Y","year":"2020","unstructured":"Wang Y, Beydoun MA, Min J, Xue H, Kaminsky LA, Cheskin LJ. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020, 49:810-23. 10.1093\/ije\/dyz273","journal-title":"Int J Epidemiol"},{"key":"ref4","article-title":"Obesity: lifestyle modification and behavior interventions","volume":"492","author":"Wilson K","year":"2020","unstructured":"Wilson K. Obesity: lifestyle modification and behavior interventions. FP Essent. 2020, 492:19-24.","journal-title":"FP Essent"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs A","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity management in adults: a review. JAMA. 2023, 330:2000-15. 10.1001\/jama.2023.19897","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ans.19378","article-title":"Metabolic bariatric surgery generates substantial, sustained weight loss and health improvement in a real-world setting","author":"Brown WA","year":"2025","unstructured":"Brown WA, Brown DL, Holland JF, et al.. Metabolic bariatric surgery generates substantial, sustained weight loss and health improvement in a real-world setting. ANZ J Surg. 2025, 10.1111\/ans.19378","journal-title":"ANZ J Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000317","article-title":"Metabolic and bariatric surgery utilization trends in the United States: evidence from 2012 to 2021 national electronic medical records network","volume":"4","author":"Alsuhibani A","year":"2023","unstructured":"Alsuhibani A, Thompson JR, Wigle PR, Guo JJ, Lin AC, Rao MB, Hincapie AL. Metabolic and bariatric surgery utilization trends in the United States: evidence from 2012 to 2021 national electronic medical records network. Ann Surg Open. 2023, 4:e317. 10.1097\/AS9.0000000000000317","journal-title":"Ann Surg Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2018.10.005","article-title":"Reasons for underutilization of bariatric surgery: the role of insurance benefit design","volume":"15","author":"Gasoyan H","year":"2019","unstructured":"Gasoyan H, Tajeu G, Halpern MT, Sarwer DB. Reasons for underutilization of bariatric surgery: the role of insurance benefit design. Surg Obes Relat Dis. 2019, 15:146-51. 10.1016\/j.soard.2018.10.005","journal-title":"Surg Obes Relat Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding JP","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al.. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. 10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff AM","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022, 387:205-16. 10.1056\/NEJMoa2206038","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbj.2017.01.008","article-title":"A brief history of bariatric surgery","volume":"2","author":"Faria GR","year":"2017","unstructured":"Faria GR. A brief history of bariatric surgery. Porto Biomed J. 2017, 2:90-2. 10.1016\/j.pbj.2017.01.008","journal-title":"Porto Biomed J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2016.03.001","article-title":"A history of bariatric surgery: the maturation of a medical discipline","volume":"96","author":"Celio AC","year":"2016","unstructured":"Celio AC, Pories WJ. A history of bariatric surgery: the maturation of a medical discipline. Surg Clin North Am. 2016, 96:655-67. 10.1016\/j.suc.2016.03.001","journal-title":"Surg Clin North Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2011.08.002","article-title":"The history and evolution of bariatric surgical procedures","volume":"91","author":"Baker MT","year":"2011","unstructured":"Baker MT. The history and evolution of bariatric surgical procedures. Surg Clin North Am. 2011, 91:1181-201, viii. 10.1016\/j.suc.2011.08.002","journal-title":"Surg Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2014.12.023","article-title":"A tribute to Dr. Edward E. Mason, M.D","volume":"11","author":"Maher JW","year":"2015","unstructured":"Maher JW. A tribute to Dr. Edward E. Mason, M.D. Surg Obes Relat Dis. 2015, 11:284-5. 10.1016\/j.soard.2014.12.023","journal-title":"Surg Obes Relat Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2005.01.005","article-title":"History of obesity surgery","volume":"1","author":"Mason EE","year":"2005","unstructured":"Mason EE. History of obesity surgery. Surg Obes Relat Dis. 2005, 1:123-5. 10.1016\/j.soard.2005.01.005","journal-title":"Surg Obes Relat Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.12.010","article-title":"The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy","volume":"79","author":"Phillips BT","year":"2018","unstructured":"Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018, 79:97-107. 10.1016\/j.metabol.2017.12.010","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14020151","article-title":"Advancements in bariatric surgery: a comparative review of laparoscopic and robotic techniques","volume":"14","author":"Velardi AM","year":"2024","unstructured":"Velardi AM, Anoldo P, Nigro S, Navarra G. Advancements in bariatric surgery: a comparative review of laparoscopic and robotic techniques. J Pers Med. 2024, 14:14. 10.3390\/jpm14020151","journal-title":"J Pers Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2023.08.017","article-title":"Lessons learned from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program site surveys: common deficiencies and corrective actions","volume":"20","author":"Morton JM","year":"2024","unstructured":"Morton JM, English W, Jones D, Provost DA. Lessons learned from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program site surveys: common deficiencies and corrective actions. Surg Obes Relat Dis. 2024, 20:154-9. 10.1016\/j.soard.2023.08.017","journal-title":"Surg Obes Relat Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66500","article-title":"Long-term effectiveness and outcomes of bariatric surgery: a comprehensive review of current evidence and emerging trends","volume":"16","author":"Ram Sohan P","year":"2024","unstructured":"Ram Sohan P, Mahakalkar C, Kshirsagar S, Bikkumalla S, Reddy S, Hatewar A, Dixit S. Long-term effectiveness and outcomes of bariatric surgery: a comprehensive review of current evidence and emerging trends. Cureus. 2024, 16:e66500. 10.7759\/cureus.66500","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12657","article-title":"Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles","volume":"18","author":"Krentz AJ","year":"2016","unstructured":"Krentz AJ, Fujioka K, Hompesch M. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles. Diabetes Obes Metab. 2016, 18:558-70. 10.1111\/dom.12657","journal-title":"Diabetes Obes Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12771","article-title":"Weight management in obesity - past and present","volume":"70","author":"Haslam D","year":"2016","unstructured":"Haslam D. Weight management in obesity - past and present. Int J Clin Pract. 2016, 70:206-17. 10.1111\/ijcp.12771","journal-title":"Int J Clin Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.009621","article-title":"Anti-obesity drugs: past, present and future","volume":"5","author":"Rodgers RJ","year":"2012","unstructured":"Rodgers RJ, Tsch\u00f6p MH, Wilding JP. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012, 5:621-6. 10.1242\/dmm.009621","journal-title":"Dis Model Mech"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.41380","article-title":"Metabolic bariatric surgery in the era of GLP-1 receptor agonists for obesity management","volume":"7","author":"Lin K","year":"2024","unstructured":"Lin K, Mehrotra A, Tsai TC. Metabolic bariatric surgery in the era of GLP-1 receptor agonists for obesity management. JAMA Netw Open. 2024, 7:e2441380. 10.1001\/jamanetworkopen.2024.41380","journal-title":"JAMA Netw Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(97)00289-8","article-title":"A close look at fenfluramine and dexfenfluramine","volume":"16","author":"Vivero LE","year":"1998","unstructured":"Vivero LE, Anderson PO, Clark RF. A close look at fenfluramine and dexfenfluramine. J Emerg Med. 1998, 16:197-205. 10.1016\/s0736-4679(97)00289-8","journal-title":"J Emerg Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00928.x","article-title":"Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke","volume":"47","author":"Derby LE","year":"1999","unstructured":"Derby LE, Myers MW, Jick H. Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. Br J Clin Pharmacol. 1999, 47:565-9. 10.1046\/j.1365-2125.1999.00928.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0210-7","article-title":"Benefit-risk assessment of orlistat in the treatment of obesity","volume":"37","author":"Sumithran P","year":"2014","unstructured":"Sumithran P, Proietto J. Benefit-risk assessment of orlistat in the treatment of obesity. Drug Saf. 2014, 37:597-608. 10.1007\/s40264-014-0210-7","journal-title":"Drug Saf"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1703109","article-title":"Efficacy and safety of lorcaserin in obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Singh AK","year":"2020","unstructured":"Singh AK, Singh R. Efficacy and safety of lorcaserin in obesity: a systematic review and meta-analysis of randomized controlled trials. Expert Rev Clin Pharmacol. 2020, 13:183-90. 10.1080\/17512433.2020.1703109","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng Z","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024, 9:234. 10.1038\/s41392-024-01931-z","journal-title":"Signal Transduct Target Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.001045","article-title":"Emerging pharmacotherapies for obesity: a systematic review","volume":"77","author":"Kokkorakis M","year":"2025","unstructured":"Kokkorakis M, Chakhtoura M, Rhayem C, Al Rifai J, Ghezzawi M, Valenzuela-Vallejo L, Mantzoros CS. Emerging pharmacotherapies for obesity: a systematic review. Pharmacol Rev. 2025, 77:100002. 10.1124\/pharmrev.123.001045","journal-title":"Pharmacol Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-020-00422-w","article-title":"Long-term efficacy and safety of anti-obesity treatment: where do we stand?","volume":"10","author":"Tak YJ","year":"2021","unstructured":"Tak YJ, Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand?. Curr Obes Rep. 2021, 10:14-30. 10.1007\/s13679-020-00422-w","journal-title":"Curr Obes Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.200010","article-title":"Anti-obesity drugs: Long-term efficacy and safety: an updated review","volume":"39","author":"Tak YJ","year":"2021","unstructured":"Tak YJ, Lee SY. Anti-obesity drugs: Long-term efficacy and safety: an updated review. World J Mens Health. 2021, 39:208-21. 10.5534\/wjmh.200010","journal-title":"World J Mens Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5339\/gcsp.2014.8","article-title":"STAMPEDE: bariatric surgery gains more evidence based support","volume":"2014","author":"Al Suwaidi J","year":"2014","unstructured":"Al Suwaidi J. STAMPEDE: bariatric surgery gains more evidence based support. Glob Cardiol Sci Pract. 2014, 2014:45-8. 10.5339\/gcsp.2014.8","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12012","article-title":"Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery","volume":"273","author":"Sj\u00f6str\u00f6m L","year":"2013","unstructured":"Sj\u00f6str\u00f6m L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013, 273:219-34. 10.1111\/joim.12012","journal-title":"J Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey WT","year":"2022","unstructured":"Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022, 28:2083-91. 10.1038\/s41591-022-02026-4","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension","volume":"24","author":"Wilding JP","year":"2022","unstructured":"Wilding JP, Batterham RL, Davies M, et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022, 24:1553-64. 10.1111\/dom.14725","journal-title":"Diabetes Obes Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2017.10.002","article-title":"Efficacy of adjuvant weight loss medication after bariatric surgery","volume":"14","author":"Nor Hanipah Z","year":"2018","unstructured":"Nor Hanipah Z, Nasr EC, Bucak E, Schauer PR, Aminian A, Brethauer SA, Cetin D. Efficacy of adjuvant weight loss medication after bariatric surgery. Surg Obes Relat Dis. 2018, 14:93-8. 10.1016\/j.soard.2017.10.002","journal-title":"Surg Obes Relat Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357259-the-impact-of-new-weight-loss-medications-on-bariatric-surgery-and-surgeon-employment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T16:32:22Z","timestamp":1746981142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357259-the-impact-of-new-weight-loss-medications-on-bariatric-surgery-and-surgeon-employment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.83903","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,11]]}}}